Literature DB >> 17686236

[Effect of long-term continuous positive airway pressure ventilation on blood pressure in patients with obstructive sleep apnea hypopnea syndrome: a meta-analysis of clinical trials].

Li Mo1, Quan-ying He.   

Abstract

OBJECTIVE: To explore whether long-term continuous positive airway pressure (CPAP) ventilation is effective to decrease the blood pressure in the patients with obstructive sleep apnea hypopnea syndrome (OSAHS) accompanied with hypertension.
METHODS: Literatures of relevant randomized, controlled, prospective, clinical trials 2000 - 2006 in English and Chinese were retrieved from Medline and CNKI based on the criteria: the subjects being patients with OSAHS, the study lasting at least 4 weeks, and the effect on 24 hours ambulatory blood pressure in CPAP group being compared with that in no-CPAP group. The data thus collected underwent meta-analysis. RESULT: 471 cases in 7 studies were included. Three of the 7 studies indicated that CPAP ventilation could decrease the diastolic blood pressure in the patients with OSAHS and four studies showed no significant difference in the effect of CPAP on blood pressure between the two groups. From meta-analysis, the weighted mean difference (WMD) in fixed effect model of 24 h diastolic blood pressure (DBP) was -1.78 [95% CI: -3.34, -0.22]; the WMD (fixed) of 24 h systolic blood pressure (SBP) was -0.95 [95% CI: -2.85, 0.94], and the WMD (random) of 24 h mean blood pressure (MBP) was -1.25 [95% CI: -4.00, 1.49].
CONCLUSION: The long-term CPAP ventilation can decrease the 24 h DBP.

Entities:  

Mesh:

Year:  2007        PMID: 17686236

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  11 in total

1.  Sleep and hypertension.

Authors:  David A Calhoun; Susan M Harding
Journal:  Chest       Date:  2010-08       Impact factor: 9.410

Review 2.  Obstructive sleep apnea and hypertension.

Authors:  David A Calhoun
Journal:  Curr Hypertens Rep       Date:  2010-06       Impact factor: 5.369

Review 3.  Resistant hypertension, obstructive sleep apnoea and aldosterone.

Authors:  T Dudenbostel; D A Calhoun
Journal:  J Hum Hypertens       Date:  2011-06-09       Impact factor: 3.012

Review 4.  Sympathetic Nervous System, Sleep, and Hypertension.

Authors:  Gino Seravalle; Giuseppe Mancia; Guido Grassi
Journal:  Curr Hypertens Rep       Date:  2018-07-06       Impact factor: 5.369

5.  Continuous positive airway pressure therapy in non-sleepy patients with obstructive sleep apnea: results of a meta-analysis.

Authors:  Dongmei Zhang; Jinmei Luo; Yixian Qiao; Yi Xiao
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

6.  Effects of continuous positive airway pressure on blood pressure and daytime sleepiness in obstructive sleep apnea patients with coronary heart diseases under optimal medications.

Authors:  Qing Zhao; Zhi-Hong Liu; Qin Luo; Zhi-Hui Zhao; Hong-Liang Zhang; Yong Wang
Journal:  Sleep Breath       Date:  2011-02-22       Impact factor: 2.816

Review 7.  Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences.

Authors:  Shahrokh Javaheri; Ferran Barbe; Francisco Campos-Rodriguez; Jerome A Dempsey; Rami Khayat; Sogol Javaheri; Atul Malhotra; Miguel A Martinez-Garcia; Reena Mehra; Allan I Pack; Vsevolod Y Polotsky; Susan Redline; Virend K Somers
Journal:  J Am Coll Cardiol       Date:  2017-02-21       Impact factor: 24.094

8.  Sleep apnea: secondary cause or risk factor for hypertension?

Authors:  Costas Thomopoulos; Kyriakos Dimitriadis; Alexandros Kasiakogias; Costas Tsioufis
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-04-24       Impact factor: 3.738

9.  4-Hydroxychalcone attenuates hyperaldosteronism, inflammation, and renal injury in cryptochrome-null mice.

Authors:  Qi Qu; Bingguang Dai; Bo Yang; Xuelian Li; Yimin Liu; Fuling Zhang
Journal:  Biomed Res Int       Date:  2014-06-09       Impact factor: 3.411

10.  Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials.

Authors:  Daniel J Bratton; John R Stradling; Ferran Barbé; Malcolm Kohler
Journal:  Thorax       Date:  2014-06-19       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.